Analyst Ratings for Pyxis Oncology Inc. (PYXS)
PYXS Rating Summary
PYXS Price Target Summary
- Highest: $8.00 (Stephens)
- Lowest: $5.00 (RBC Capital)
- Average: $6.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.75 (+392.7%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 90%
Avg. $ Target:
$6.75 (+392.7%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/4/2025 | Guggenheim » Updated 11/4/2025 |
Bradley Canino | New Coverage | Buy (N/A) |
7.00 (5.00) |
1.33 (1.37) |
3.01% | Details |
| 11/8/2024 | Stephens » Updated 11/24/2025 |
Sudan Loganthan | New Coverage | Overweight (N/A) |
8.00 (5.00) |
4.02 (1.37) |
-65.92% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
